Published in Nature on December 26, 1984
Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol (1994) 4.30
Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature (2007) 3.06
Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis. J Cell Biol (1986) 2.73
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A (1999) 2.42
Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol Appl Pharmacol (2007) 2.17
In situ imaging of metals in cells and tissues. Chem Rev (2009) 2.03
Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A (1996) 1.91
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. Proc Natl Acad Sci U S A (1991) 1.85
Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res (1999) 1.68
Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor. Immunology (1985) 1.62
Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol (2003) 1.55
Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res (2007) 1.54
Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci U S A (1994) 1.50
Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol (1992) 1.48
Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses. Proc Natl Acad Sci U S A (2008) 1.47
Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin Exp Immunol (2003) 1.39
Albumin interacts specifically with a 60-kDa microvascular endothelial glycoprotein. Proc Natl Acad Sci U S A (1988) 1.38
Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog (2009) 1.37
Establishment and characterization of an immortalized Z310 choroidal epithelial cell line from murine choroid plexus. Brain Res (2002) 1.35
Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci U S A (1985) 1.35
Transferrin and transferrin receptor function in brain barrier systems. Cell Mol Neurobiol (2000) 1.29
Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci U S A (1987) 1.27
The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One (2012) 1.27
Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx (2005) 1.27
Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. Proc Natl Acad Sci U S A (1985) 1.26
Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther (2006) 1.26
MRC OX-43: a monoclonal antibody which reacts with all vascular endothelium in the rat except that of brain capillaries. Immunology (1986) 1.24
Toxicology of choroid plexus: special reference to metal-induced neurotoxicities. Microsc Res Tech (2001) 1.24
Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. Immunology (1987) 1.24
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human. Proc Natl Acad Sci U S A (1990) 1.23
Brain induces the expression of an early cell surface marker for blood-brain barrier-specific endothelium. EMBO J (1986) 1.22
Aptamer-based endocytosis of a lysosomal enzyme. Proc Natl Acad Sci U S A (2008) 1.21
Immunotherapy of malignant brain tumors. Immunol Rev (2008) 1.20
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proc Natl Acad Sci U S A (2002) 1.19
Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol (2005) 1.17
Modulation of CD4 antigen on macrophages and microglia in rat brain. J Exp Med (1987) 1.15
FACS purification of immunolabeled cell types from adult rat brain. J Neurosci Methods (2011) 1.15
Transendothelial transport of serum albumin: a quantitative immunocytochemical study. J Cell Biol (1992) 1.14
Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol (1997) 1.11
Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol (1991) 1.11
Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx (2005) 1.10
Neurotoxicology of the brain barrier system: new implications. J Toxicol Clin Toxicol (2001) 1.09
Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. J Neurochem (2004) 1.08
Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model. Proc Natl Acad Sci U S A (1987) 1.08
Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. Proc Natl Acad Sci U S A (1995) 1.07
Genetics of iron regulation and the possible role of iron in Parkinson's disease. Neurobiol Dis (2008) 1.07
Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro. J Cell Biol (1990) 1.06
Developing therapeutic antibodies for neurodegenerative disease. Neurotherapeutics (2013) 1.05
Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med (1992) 1.04
A genomic comparison of in vivo and in vitro brain microvascular endothelial cells. J Cereb Blood Flow Metab (2007) 1.02
Dynamic factors controlling targeting nanocarriers to vascular endothelium. Curr Drug Metab (2012) 1.02
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci U S A (1993) 1.01
Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancer. Proc Natl Acad Sci U S A (1986) 1.01
Blood-brain barrier and new approaches to brain drug delivery. West J Med (1992) 0.99
Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS One (2011) 0.98
Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Future Med Chem (2010) 0.98
Transferrin-antibody fusion proteins are effective in brain targeting. Proc Natl Acad Sci U S A (1995) 0.98
Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol (2014) 0.96
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants. J Exp Med (2014) 0.96
Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive. J Exp Med (1993) 0.95
Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery. Cancer Res (2010) 0.95
Barrier properties of testis microvessels. Proc Natl Acad Sci U S A (1993) 0.95
Aluminum access to the brain: a role for transferrin and its receptor. Proc Natl Acad Sci U S A (1990) 0.94
Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies. Curr Med Chem (2014) 0.94
Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers. Curr Pharm Des (2010) 0.94
Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor. J Inherit Metab Dis (2012) 0.93
Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci U S A (1993) 0.91
In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J Cereb Blood Flow Metab (2016) 0.90
Targeting receptors, transporters and site of absorption to improve oral drug delivery. Drug Target Insights (2007) 0.90
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor. J Clin Invest (1997) 0.89
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc Natl Acad Sci U S A (1995) 0.89
A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrier. PLoS One (2008) 0.89
A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain. PLoS One (2011) 0.89
Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells. ACS Chem Neurosci (2013) 0.88
Modulation of the expression of integrins on glial cells during experimental autoimmune encephalomyelitis. A central role for TNF-alpha. Am J Pathol (1997) 0.88
Development of transferrin functionalized poly(ethylene glycol)/poly(lactic acid) amphiphilic block copolymeric micelles as a potential delivery system targeting brain glioma. J Mater Sci Mater Med (2010) 0.84
Intravenous administration of a transferrin receptor antibody-nerve growth factor conjugate prevents the degeneration of cholinergic striatal neurons in a model of Huntington disease. Proc Natl Acad Sci U S A (1994) 0.84
How protein hormones reach their target cells. Receptor-mediated transcytosis of hCG through endothelial cells. J Cell Biol (1994) 0.83
In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors. Biomaterials (2013) 0.83
Cognitive deterioration and associated pathology induced by chronic low-level aluminum ingestion in a translational rat model provides an explanation of Alzheimer's disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis (2012) 0.81
A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding. PLoS One (2014) 0.81
Deficiency of Calcium-Independent Phospholipase A2 Beta Induces Brain Iron Accumulation through Upregulation of Divalent Metal Transporter 1. PLoS One (2015) 0.80
Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Front Mol Neurosci (2015) 0.79
A DNA-Device that Mediates Selective Endosomal Escape and Intracellular Delivery of Drugs and Biologicals. Adv Funct Mater (2014) 0.79
Transferrin receptors in injured brain. Acta Neuropathol (1990) 0.79
Differential tissue localization of oviduct and erythroid transferrin receptors. Proc Natl Acad Sci U S A (1991) 0.79
Targeting specific cells in the brain with nanomedicines for CNS therapies. J Control Release (2015) 0.79
Expression and upregulation of transferrin receptors and iron uptake in the epiplexus cells of different aged rats injected with lipopolysaccharide and interferon-gamma. J Anat (1995) 0.79
T2 shortening in childhood moyamoya disease. Neuroradiology (1996) 0.79
Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation. J Parkinsons Dis (2015) 0.78
OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma. Mol Cancer (2014) 0.78
Transferrin and transferrin receptor in human hypophysis and pituitary adenomas. Am J Pathol (1998) 0.78
Expression and cellular localization of hepcidin mRNA and protein in normal rat brain. BMC Neurosci (2015) 0.78
Lymphocyte expression of a 90 kD brush border antigen. Clin Exp Immunol (1987) 0.77
Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation. Anticancer Agents Med Chem (2011) 0.77
Strategies for enhanced drug delivery to the central nervous system. Indian J Pharm Sci (2010) 0.77
Transferrin Receptor 1 Facilitates Poliovirus Permeation of Mouse Brain Capillary Endothelial Cells. J Biol Chem (2015) 0.77
Transient expression of transferrin receptors and localisation of iron in amoeboid microglia in postnatal rats. J Anat (1995) 0.77
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00
Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem (1984) 18.48
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell (1978) 14.82
Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell (1977) 8.46
Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu Rev Biochem (1988) 7.57
Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol (1980) 5.98
Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur J Immunol (1979) 5.55
An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34
The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol (2000) 5.21
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Evaluation of programs designed to increase the protection of infants in cars. Pediatrics (1978) 4.51
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol (1990) 4.42
The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem J (1980) 4.37
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med (1993) 4.05
The distribution of muramidase (lysozyme) in human tissues. J Clin Pathol (1975) 4.03
Neuronal cell Thy-1 glycoprotein: homology with immunoglobulin. Science (1982) 4.00
The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes. Eur J Immunol (1974) 3.88
Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes. Eur J Immunol (1979) 3.69
Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood (1998) 3.67
Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med (1983) 3.63
Ki67 protein: the immaculate deception? Histopathology (2002) 3.61
Identification of marrow-derived and thymus-derived small lymphocytes in the lymphoid tissue and thoracic duct lymph of normal rats. J Exp Med (1972) 3.54
The Bloom's syndrome gene product interacts with topoisomerase III. J Biol Chem (2000) 3.52
Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol (1978) 3.36
Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol (1987) 3.36
Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol (1983) 3.23
A repopulation assay for B and T lymphocyte stem cells employing radiation chimaeras. Cell Tissue Kinet (1981) 3.23
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
Observed child restraint use in automobiles. Am J Dis Child (1976) 3.20
T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody. J Exp Med (1978) 3.20
The normal and malignant germinal centre. Clin Haematol (1982) 3.19
Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med (1985) 3.16
Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes. Eur J Immunol (1985) 3.14
Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer (2001) 3.10
JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol (1990) 3.10
Monoclonal antibody Ki-67: its use in histopathology. Histopathology (1990) 3.07
A glycophospholipid tail at the carboxyl terminus of the Thy-1 glycoprotein of neurons and thymocytes. Science (1985) 3.05
Antigens on mouse and rat lymphocytes recognized by rabbit antiserum against rat brain: the quantitative analysis of a xenogeneic antiserum. Eur J Immunol (1975) 2.92
Identification of a glycophorin-like molecule at the cell surface of rat thymocytes. Nature (1981) 2.88
Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A (1991) 2.82
KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol (1989) 2.82
Crystal structure at 2.8 A resolution of a soluble form of the cell adhesion molecule CD2. Nature (1992) 2.76
Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics (2000) 2.73
MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen. J Exp Med (1983) 2.72
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol (2001) 2.71
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol (1982) 2.69
Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol (1982) 2.67
Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region. Biochem J (1981) 2.63
The Tennessee child restraint law in its third year. Am J Public Health (1981) 2.56
Purification of human C3b inactivator by monoclonal-antibody affinity chromatography. Biochem J (1982) 2.53
Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol (1995) 2.52
Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer (1982) 2.51
Evaluation of the Tennessee Child Restraint Law. Am J Public Health (1979) 2.49
Ultrastructural localization of bcl-2 protein. J Histochem Cytochem (1992) 2.48
Analysis in deoxycholate of three antigenic specificities associated with the rat Thy-1 molecule. Eur J Immunol (1975) 2.44
Evidence from cDNA clones that the rat leukocyte-common antigen (T200) spans the lipid bilayer and contains a cytoplasmic domain of 80,000 Mr. Cell (1985) 2.43
Classifying urban crashes for countermeasure development. Accid Anal Prev (1995) 2.43
Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest (1986) 2.42
ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood (1998) 2.41
Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood (1990) 2.40
Surface antigens, SBU-T4 and SBU-T8, of sheep T lymphocyte subsets defined by monoclonal antibodies. Immunology (1985) 2.40
Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques. Lancet (1985) 2.40
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res (2001) 2.38
Structure of domain 1 of rat T lymphocyte CD2 antigen. Nature (1991) 2.31
Antibody and HIV-1 gp120 recognition of CD4 undermines the concept of mimicry between antibodies and receptors. Nature (1992) 2.27
Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet (1985) 2.25
Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms. Lancet (1984) 2.25
Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest (1985) 2.23
Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res (1994) 2.21
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer (2003) 2.20
Association between platelet microthrombi and finger clubbing. Lancet (1991) 2.20
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol (1997) 2.19
Characterization of two sheep lymphocyte differentiation antigens, SBU-T1 and SBU-T6. Immunology (1985) 2.18
Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet (1984) 2.17
Monoclonal antibodies to Ia antigens from rat thymus: cross reactions with mouse and human and use in purification of rat Ia glycoproteins. Immunol Rev (1979) 2.17
Complete structure of the glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1 glycoprotein. Nature (1988) 2.17
CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med (1992) 2.13
Chemical characterisation of the Thy-1 glycoproteins from the membranes of rat thymocytes and brain. Nature (1976) 2.12
The presence of IgA on the surface of rat thoractic duct lymphocytes which contain internal IgA. J Exp Med (1975) 2.08
Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol (1998) 2.05